touchIMMUNOLOGY was delighted to speak with Dr Aurélie Najm (University of Glasgow, Glasgow, UK) about B-cell repertoire changes in patients with rheumatoid arthritis and the recent analysis designed to create a nomogram capable of using B-cell repertoire properties to predict response to methotrexate.
This information is brought to you by Touch Medical Media and is not sponsored by, nor a part of, the American College of Rheumatology.
The analysis entitled ‘B Cells Repertoire Repartition Predicts Response to Methotrexate at 6 and 12 Months in Naïve RA: A Machine Learning Driven Approach’ (ABSTRACT NUMBER: 0982) was presented at the ACR Convergence, 5-9 November 2021.
Questions
- How does the B cell repertoire change in rheumatoid arthritis according to treatment response? (0:19)
- Could you tell us a little about the machine learning based approach you have developed for predicting response to methotrexate? (1:02)
- What were the aims, design of your study assessing this model? (1:57)
- What were the study findings? (2:50)
- What will be the potential impact of this approach on clinical practice? (4:02)
Disclosures: Dr Aurélie Najm has acted as a consultant for BMS, UCB and Chugai; and as a speaker for UCB.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Gina Furnival.
Filmed in coverage of virtual ACR Convergence 2021.
